Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4026
Zai Lab
ZLAB
$2.73B
| $264K | ﹤0.01% |
7,538
+2,836
| +60% | +$93.2K |
2022 Q1
13 quarters
|
|
4027
Epsilon Energy
EPSN
$174M
| $262K | ﹤0.01% |
35,525
+35,303
| +15,902% | +$252K |
2024 Q3
3 quarters
|
|
4028
Rocky Brands
RCKY
$350M
| $262K | ﹤0.01% |
11,813
+4,341
| +58% | +$82.7K |
2018 Q2
28 quarters
|
|
4029
Ironwood Pharmaceuticals
IRWD
$601M
| $262K | ﹤0.01% |
365,450
+36,061
| +11% | +$28.3K |
2013 Q2
48 quarters
|
|
4030
Definitive Healthcare
DH
$99.6M
| $261K | ﹤0.01% |
67,000
+4,822
| +8% | +$15.2K |
2022 Q1
13 quarters
|
|
4031
Monopar Therapeutics
MNPR
$523M
| $261K | ﹤0.01% |
7,285
+7,273
| +60,608% | +$264K |
2025 Q1
1 quarter
|
|
|
CRGX
4032
DELISTED
CARGO Therapeutics
CRGX
| $261K | ﹤0.01% |
63,260
+19,067
| +43% | +$81.7K |
2024 Q1
5 quarters
|
|
4033
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$4.02B
| $260K | ﹤0.01% |
3,152
| – | – |
2013 Q2
48 quarters
|
|
4034
Transportadora de Gas del Sur
TGS
$3.77B
| $259K | ﹤0.01% |
+10,000
| New | +$274K |
2025 Q2
0 quarters
|
|
|
CHYM
4035
Chime Financial
CHYM
$10.3B
| $259K | ﹤0.01% |
+7,500
| New | +$247K |
2025 Q2
0 quarters
|
|
4036
Franklin Financial Services
FRAF
$284M
| $258K | ﹤0.01% |
7,465
+7,445
| +37,225% | +$275K |
2024 Q3
3 quarters
|
|
|
JCAP
4037
Jefferson Capital
JCAP
$1.11B
| $258K | ﹤0.01% |
+14,000
| New | +$261K |
2025 Q2
0 quarters
|
|
4038
FinWise Bancorp
FINW
$155M
| $257K | ﹤0.01% |
17,118
+11,151
| +187% | +$164K |
2024 Q3
3 quarters
|
|
4039
Vanguard Morningstar Mid-Cap ETF
VO
$104B
| $257K | ﹤0.01% |
3,668
| – | – |
2020 Q2
20 quarters
|
|
4040
Pioneer Bancorp
PBFS
$430M
| $255K | ﹤0.01% |
21,220
+7,181
| +51% | +$82.5K |
2022 Q1
13 quarters
|
|
|
EFXT
4041
Enerflex
EFXT
$3B
| $255K | ﹤0.01% |
32,339
+1,107
| +4% | +$7.92K |
2023 Q1
9 quarters
|
|
4042
CS Disco
LAW
$271M
| $254K | ﹤0.01% |
58,224
+27,559
| +90% | +$108K |
2022 Q1
13 quarters
|
|
4043
Acme United Corp
ACU
$243M
| $254K | ﹤0.01% |
6,134
+4,242
| +224% | +$167K |
2024 Q3
3 quarters
|
|
4044
iShares Short Maturity Bond ETF
NEAR
$5.1B
| $254K | ﹤0.01% |
4,970
| – | – |
2023 Q1
9 quarters
|
|
|
NXDT
4045
NexPoint Diversified Real Estate Trust
NXDT
$281M
| $254K | ﹤0.01% |
60,611
+24,206
| +66% | +$90.7K |
2020 Q4
18 quarters
|
|
4046
KRONOS Worldwide
KRO
$895M
| $254K | ﹤0.01% |
40,945
+14,275
| +54% | +$97.9K |
2016 Q3
35 quarters
|
|
|
SEG
4047
Seaport Entertainment Group
SEG
$287M
| $253K | ﹤0.01% |
13,543
+13,323
| +6,056% | +$256K |
2024 Q3
3 quarters
|
|
4048
Bel Fuse Inc Class A
BELFA
$3.02B
| $252K | ﹤0.01% |
2,810
+1,049
| +60% | +$72.7K |
2024 Q1
5 quarters
|
|
|
SCPH
4049
DELISTED
scPharmaceuticals
SCPH
| $252K | ﹤0.01% |
66,199
+19,586
| +42% | +$60.8K |
2023 Q1
9 quarters
|
|
4050
EVI Industries
EVI
$248M
| $251K | ﹤0.01% |
11,514
+4,464
| +63% | +$79.6K |
2022 Q4
10 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.